← All stocks

HARROW, INC.

HROW Balanced

CIK 0001360214 #2224 in the set updated 18 Sep 2026

Bought (120 mo)

$13.88M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$14.18M

$0.00 on a plan · $450.00K straight out of an exercise

Sold at will

$13.73M

38 of 39 sales

Net

−$297.68K

+$152.32K against sales at will

By person

13 insiders · 132 transactions

190×

Mark L. Baum holds 190 times base salary in stock. $143.77M of shares against $754.91K in salary for 2025.

Salary from the company's own proxy. The shares are what Mark L. Baum last reported holding, valued at $40.00, the price Common Stock was last bought or sold at on the open market here, on 14 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BAUM MARK L

CHIEF EXECUTIVE OFFICER

$1.18M (6)

—

+$1.18M

3,594,256

9.59%

$143.77M

+345.1%

Kammer Robert J

Director

—

$1.10M (17)

−$1.10M

797,327

2.13%

$31.89M

−19.9%

Makary Martin A.

Director

$672.65K (2)

—

+$672.65K

45,000

0.1200%

$1.80M

—

LINDSTROM RICHARD L MD

Director

$179.00K (1)

$832.85K (5)

−$653.85K

216,100

0.5765%

$8.64M

+140.1%

Shojaei Amir

CHIEF SCIENTIFIC OFFICER

—

$450.00K (1) scheduled

−$450.00K

0.0000%

$0.00

—

Opaleye Management Inc. entity

10% owner

$11.55M (59)

$11.79M (16)

−$242.56K

3,955,028

10.55%

$158.20M

+37.7%

BOLL ANDREW R.

PRESIDENT AND CFO

$208.31K (3)

—

+$208.31K

814,679

2.17%

$32.59M

+5,331%

Graves Adrienne L

Director

$31.07K (1)

—

+$31.07K

1,000

0.0027%

$40.00K

—

SILVERNAIL LAUREN P

Director

$31.00K (1)

—

+$31.00K

1,000

0.0027%

$40.00K

—

Van Horn R. Lawrence

Director

$24.96K (1)

—

+$24.96K

1,860

0.0050%

$74.40K

—

SAHAREK JOHN P.

CEO & President, ImprimisRx

—

467,388

1.25%

$18.70M

—

Principi Anthony

Director

—

93,798

0.2502%

$3.75M

—

AUSTIN STEPHEN G

Director

—

91,987

0.2454%

$3.68M

+365.3%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 174

Amendments (4/A) skipped 4

Filings about a different issuer 1

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 38

Transactions with no price 0

Shares from compensation/vesting 9,083,354

Sales filed before the plan box existed 22

History held since 3 Nov 2016